We have located links that may give you full text access.
Inhaled nitrous oxide during the make stitches : Randomized double blind prospective study.
La Tunisie Médicale 2017 June
INTRODUCTION: Inhaled nitrous oxide (MEOPA) ensures short-term analgesia of a patient in spontaneous ventilation through a mask. It ensures analgesic coverage during the painful gesture while saving to the patient the phenomena of memorization.
AIM: To study the efficacy and safety of the use of MEOPA during the make stitches.
METHODS: Randomized double blind prospective study including any patient aged > 16 years admitted to the emergency for make stitches during a period of 3 months. After consent, patients were randomized to 2 groups (MEOPA versus placebo). When the stitches were made, if the patient has a VAS (visual analog scale) > 30%, an emergency analgesia with 2% subcutaneous xylocaine is performed. The primary endpoint was the degree of analgesia according to VAS. The secondary endpoints were the occurrence of side effects, patient and operator satisfaction.
RESULTS: We collected 115 patients comparable in age, sex and pain at baseline. The mean of the VAS during suturing was 11.1±5.8% (MEOPA) versus 47.8±13.9% (placebo); and the mean at the end of the procedure was 5.2±5% (MEOPA) versus 27.6±12.8% (placebo) with p=0.000. Only minor adverse events (22% versus 16%) were observed with P = 0.306.
CONCLUSION: We affirm the interest of this non-invasive, safe, innocuous analgesic technique that satisfies caregivers, patients and caregivers in suturing.
AIM: To study the efficacy and safety of the use of MEOPA during the make stitches.
METHODS: Randomized double blind prospective study including any patient aged > 16 years admitted to the emergency for make stitches during a period of 3 months. After consent, patients were randomized to 2 groups (MEOPA versus placebo). When the stitches were made, if the patient has a VAS (visual analog scale) > 30%, an emergency analgesia with 2% subcutaneous xylocaine is performed. The primary endpoint was the degree of analgesia according to VAS. The secondary endpoints were the occurrence of side effects, patient and operator satisfaction.
RESULTS: We collected 115 patients comparable in age, sex and pain at baseline. The mean of the VAS during suturing was 11.1±5.8% (MEOPA) versus 47.8±13.9% (placebo); and the mean at the end of the procedure was 5.2±5% (MEOPA) versus 27.6±12.8% (placebo) with p=0.000. Only minor adverse events (22% versus 16%) were observed with P = 0.306.
CONCLUSION: We affirm the interest of this non-invasive, safe, innocuous analgesic technique that satisfies caregivers, patients and caregivers in suturing.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app